Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart ...
Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales
Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent ...
For the first time a semaglutide weight loss drug has been approved for use in Australia to also treat cardiovascular disease ...
According to a new report by the Heart and Stroke Foundation, more people are living with congenital heart disease (CHD) as ...
For the first time in Australia, a weight loss drug has been approved to also treat cardiovascular disease in overweight and obese patients. The ...
the TGA approval re-emphasises the equal importance of overweight and obesity as a factor driving heart disease. “Also key is that the risks associated can be reduced, and that there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback